Axogen, Inc. Announces Positive Topline Results from Phase 3

AXGN: Axogen, Inc.
2022-05-04 16:01:00
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft